Lee M, Kim B K, Park S, Suh C, Park M H, Cho M J
Department of Internal Medicine, College of Medicine, Seoul National University.
J Korean Med Sci. 1988 Dec;3(4):143-9. doi: 10.3346/jkms.1988.3.4.143.
In thirty patients with acute leukemia and severe aplastic anemia receiving random single donor platelet transfusions, the development of refractoriness by consecutive platelet transfusions with cytapheresis and its relationship to the appearance of anti-platelet antibodies were investigated. The median number of platelet transfusions inducing refractoriness was 13 times, and 20% of the patients remained unrefractory despite of the repeated multiple platelet transfusions up to 20 to 25 times. The results of anti-platelet antibody tasts by the enzyme-linked immunosorbent assay(ELISA) and immunofluorescent techniques(IFT) showed no statistically significant relationship with the refractoriness (p greater than 0.1). Although there was significant correlation between the results of ELISA and IFT, both tests were insufficient to find out refractoriness even with the use of pooled platelets from multiple donors as target cells. This study shows that 13 single donor platelet transfusions result in refractoriness, that both ELISA and IFT are insufficient to detect refractoriness despite of their significant correlation, and that other methods than these are needed in order to detect alloimmunization.
在30例接受随机单供者血小板输注的急性白血病和重型再生障碍性贫血患者中,研究了通过血细胞分离术连续输注血小板导致的血小板输注无效的发生情况及其与抗血小板抗体出现的关系。导致血小板输注无效的血小板输注中位数为13次,20%的患者尽管反复多次输注血小板达20至25次仍未出现无效。通过酶联免疫吸附测定(ELISA)和免疫荧光技术(IFT)进行的抗血小板抗体检测结果与血小板输注无效无统计学显著相关性(p大于0.1)。尽管ELISA和IFT的结果之间存在显著相关性,但即使使用来自多个供者的混合血小板作为靶细胞,这两种检测方法都不足以发现血小板输注无效。本研究表明,13次单供者血小板输注会导致血小板输注无效,ELISA和IFT虽有显著相关性但都不足以检测出血小板输注无效,需要采用这些方法以外的其他方法来检测同种免疫。